News
The Latest Updates from AXIS Clinicals
AXIS Clinicals US Expands Capabilities to Conduct hADME Studies for NDA Filings
DILWORTH, Minn., Dec. 20, 2024—AXIS Clinicals US is pleased to announce the award of a Radioactive Materials License (RAM License) issued from the Minnesota Department
Clinical Partnership Announcement
AXIS Clinicals LLC and Joanneum Research Forschungsgesellschaft mbH are excited to announce the first ever partnership for the clinical applications of dermal open flow microperfusion
AXIS Clinicals, a Clinical Research Organization, welcomes Dr. Keith Gallicano as a consultant as the Senior Advisor in Clinical & Scientific Affairs.
DILWORTH, MN, 1st March, 2021 – AXIS Clinicals added another member as part of the consultation team with the welcoming of Dr. Keith Gallicano as the Senior
AXIS Continues Clinical Research During COVID-19 Restrictions
Dilworth, MN – Clinical and bioanalytical studies supporting pharmacology projects and multi-site patient trials continue at AXIS. Various projects supporting research to address the Coronavirus
AXIS Clinicals Announces ERT Certification.
Dilworth, MN – Axis Clinicals USA announces they have received ERT Certification. The Certification program ensures sites are proficient in collecting the highest quality ECG data.
AXIS Clinicals USA Announces Enhanced Clinical Pharmacology Capabilities
Dilworth, MN – AXIS Clinicals is pleased to announce the expansion of our US clinical site with the addition of 45 hospital beds, offering the